Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;37(10):2109-2116.
doi: 10.1038/s41433-022-02298-7. Epub 2022 Nov 3.

UK Biobank retinal imaging grading: methodology, baseline characteristics and findings for common ocular diseases

Collaborators, Affiliations

UK Biobank retinal imaging grading: methodology, baseline characteristics and findings for common ocular diseases

Alasdair N Warwick et al. Eye (Lond). 2023 Jul.

Erratum in

Abstract

Background/objectives: This study aims to describe the grading methods and baseline characteristics for UK Biobank (UKBB) participants who underwent retinal imaging in 2009-2010, and to characterise individuals with retinal features suggestive of age-related macular degeneration (AMD), glaucoma and retinopathy.

Methods: Non-mydriatic colour fundus photographs and macular optical coherence tomography (OCT) scans were manually graded by Central Administrative Research Facility certified graders and quality assured by clinicians of the Network of Ophthalmic Reading Centres UK. Captured retinal features included those associated with AMD (≥1 drusen, pigmentary changes, geographic atrophy or exudative AMD; either imaging modality), glaucoma (≥0.7 cup-disc ratio, ≥0.2 cup-disc ratio difference between eyes, other abnormal disc features; photographs only) and retinopathy (characteristic features of diabetic retinopathy with or without microaneurysms; either imaging modality). Suspected cases of these conditions were characterised with reference to diagnostic records, physical and biochemical measurements.

Results: Among 68,514 UKBB participants who underwent retinal imaging, the mean age was 57.3 years (standard deviation 8.2), 45.7% were men and 90.6% were of White ethnicity. A total of 64,367 participants had gradable colour fundus photographs and 68,281 had gradable OCT scans in at least one eye. Retinal features suggestive of AMD and glaucoma were identified in 15,176 and 2184 participants, of whom 125 (0.8%) and 188 (8.6%), respectively, had a recorded diagnosis. Of 264 participants identified to have retinopathy with microaneurysms, 251 (95.1%) had either diabetes or hypertension.

Conclusions: This dataset represents a valuable addition to what is currently available in UKBB, providing important insights to both ocular and systemic health.

PubMed Disclaimer

Conflict of interest statement

ANW, KC, BH, KS, AJL, PJF, MQ and SM declare no competing interests. AC’s financial interests: Consultant/Contractor (Aerie, Google Health, Novartis, Reichert, Santen, Thea, Abbvie). KB’s financial interests: Consultant/Contractor (Roche, Novartis); Financial support (Roche, Novartis, Bayer, Apellis); Recipient: (Novartis, Bayer, Roche, Alimera, Heidelberg Engineering). TP’s financial interests: Consultant/Contractor (Optos and Optomed); Recipient (Allergan, Genentech/Roche, Oxurion, Novartis, Bayer, Heidelberg, Optos, Apellis, Alimera, Bayer). APK has acted as a consultant to Abbvie, Aerie, Google Health, Novartis, Reichert, Santen and Thea.

Figures

Fig. 1
Fig. 1. Flowcharts of participants who attended for retinal imaging at ocular assessment.
OCT optical coherence tomography.
Fig. 2
Fig. 2. Comparisons of baseline measurements for HbA1c, systolic blood pressure, body mass index and total cholesterol between participants who were identified from retinal imaging to have suspected age-related macular degeneration, glaucoma, or retinopathy with or without microaneurysms.
Statistically significant pairwise comparisons (Student’s t-test) are indicated by asterisks: *p < 0.05, **p < 0.01, ***p < 0.001. MA microaneurysm.

References

    1. Fight For Sight. Time to focus. 2020. https://www.fightforsight.org.uk/media/3302/time-to-focus-report.pdf.
    1. GBD 2019 Blindness and Vision Impairment CollaboratorsVision Loss Expert Group of the Global Burden of Disease Study Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9:e144–e160. doi: 10.1016/S2214-109X(20)30489-7. - DOI - PMC - PubMed
    1. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64. doi: 10.2337/dc11-1909. - DOI - PMC - PubMed
    1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi: 10.1016/j.diabres.2017.03.024. - DOI - PubMed
    1. Demmin DL, Silverstein SM. Visual impairment and mental health: unmet needs and treatment options. Clin Ophthalmol (Auckl, N. Z.) 2020;14:4229–51. doi: 10.2147/OPTH.S258783. - DOI - PMC - PubMed